Cencora Inc. (COR) shares plummeted 8.04% during intraday trading on Wednesday, extending losses from the pre-market session.

The sharp decline followed the healthcare solutions provider's release of its fiscal first quarter 2026 results, which revealed quarterly revenue of $85.932 billion. While this represented a 5.45% increase over the same period last year, it fell short of the analyst consensus estimate of $86.027 billion.

Investors appeared to focus on the revenue miss despite the company reporting adjusted earnings per share of $4.08, which exceeded the $4.04 estimate. The market's negative reaction highlights investor sensitivity to top-line performance, even when bottom-line results beat expectations.